166 completed, 30 unknown, 19 recruiting, 18 terminated. 78 Phase 2, 58 Phase 3, 34 Not applicable, 33 Phase 1, 15 Phase 4.
Follow Skin Diseases, Parasitic: new trials by email Literature Review of Skin Diseases, Parasitic trials Research Report on Skin Diseases, Parasitic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation ivermectin infant formula preparation, Standard ivermectin 3mg tablet - Scabies | Phase 1 | Suspended | Murdoch Childrens Research Institute | 52 | 2027-01-01 | 2026-10-09 |
| Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL) Sodium Stibogluconate (SSG), Miltefosine, Miltefosine + Paromomycin - Cutaneous Leihmaniasis | Phase 3 | Not yet recruiting | Institute of Tropical Medicine, Belgium | 900 | 2027-01-01 | 2026-03-10 |
| Immersive Technology Headsets to Reduce Procedural Pain and Anxiety: Feasibility and Effects in Cutaneous Leishmaniasis Patients in Pakistan Virtual Reality - Cutaneous Leishmaniasis, Pain | Not applicable | Not yet recruiting | Stanford University | 15 | 2027-01-01 | 2026-10-05 |
| Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic Dermatitis Atopic Dermatitis (AD), Scabies | Not yet recruiting | Istanbul Medeniyet University | 51 | 2026-10-01 | 2026-09-15 | |
| Better Options for Lymphatic Filariasis Treatment MoxDA - Moxidectin + Diethylcarbamzine (DEC) + Albendazole, IDA - Ivermectin + DEC + albendazole - Lymphatic Filariasis, Scabies | Phase 3 | Recruiting | Medicines Development for Global Health | 5100 | 2026-09-28 | 2026-10-07 |
| Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations Modified Mass Administration of Medicines Strategy, Albendazole 400 mg, Praziquantel 40 mg/kg - Onchocerciasis (River Blindness), Schistosomiasis | Not applicable | Recruiting | Uwemedimo Friday Ekpo | 5760 | 2026-07-01 | 2026-07-16 |
| Ex Vivo Immunogenicity Screening of Vaccine Candidate Antigen Combinations in Ethiopian Patients With Leishmaniasis Leishmaniasis, Cutaneous, Leishmaniasis | Recruiting | Institute of Tropical Medicine, Belgium | 90 | 2026-05-26 | 2026-08-24 | |
| Safety, Efficacy and Preventative Effect of a Head Lice Product (X92001483) vs. Nix Creme Rinse (1% Permethrin). Medical Device (X92001483) - Lice; Head Lice | Not applicable | Recruiting | Oystershell NV | 98 | 2026-05-01 | 2026-06-22 |
| Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers A mobile app with AI functionality for diagnosing skin-related NTDs - Skin and Connective Tissue Diseases, Neglected Tropical Diseases | Not applicable | Not yet recruiting | Kenya Medical Research Institute | 2420 | 2026-05-01 | 2026-04-02 |
| Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II. Arnica Tincture, Meglumine antimoniate. - Leishmaniasis, Cutaneous | Phase 3 | Recruiting | Universidad de Antioquia | 96 | 2026-03-11 | 2026-04-02 |
| Efficacy and Safetyof a Medical Device With a Physical Mode of Action (X92001919) Versus Paranix Anti-lice Shampoo. Pulverize (X92001919), Paranix Anti-Lice Shampoo - Lice; Head Lice | Not applicable | Not yet recruiting | Oystershell NV | 34 | 2026-02-01 | 2025-11-24 |
| Comparison of Permethrin-Based Treatment Strategies Against Scabies in Infants and Young Children Permethrin 5% - Scabies | Early Phase 1 | Not yet recruiting | College of Physicians and Surgeons Pakistan | 68 | 2026-01-15 | 2026-02-03 |
| Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis MILTEFOSINE gel - Cutaneous Leishmaniasis, Cutaneous Leishmaniasis, American | Phase 1 | Not yet recruiting | Universidad Industrial de Santander | 15 | 2026-01-01 | 2025-09-08 |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective Dengue, Chikungunya | Recruiting | Institut Pasteur du Cambodge | 10000 | 2025-12-18 | 2026-01-22 | |
| Integrating Mental Health Into Neglected Tropical Disease Care in Ghana WHO Essential Care package for mental health and NTDs - Leprosy, Lymphatic Filariases | Not applicable | Not yet recruiting | Liverpool School of Tropical Medicine | 200 | 2025-11-01 | 2025-11-25 |
| Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases Moxidectin, Ivermectin - Onchocerciasis, Ascaris Lumbricoides Infection | Phase 4 | Recruiting | Kirby Institute | 52000 | 2025-08-04 | 2025-11-21 |
| Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study) Ivermectin Tablets - Scabies; Itch, Scabies | Phase 2 | Active not recruiting | Murdoch Childrens Research Institute | 120 | 2025-06-24 | 2026-10-16 |
| Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies Permethrin Cream, 5%, Ivermectin 200 µg/kg - Scabies | Phase 2 | Not yet recruiting | Children Hospital and Institute of Child Health, Lahore | 90 | 2025-05-01 | 2025-04-20 |
| Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup Thermotherapy - Cutaneous Leishmaniasis | Not applicable | Recruiting | Armauer Hansen Research Institute, Ethiopia | 103 | 2025-04-24 | 2026-10-16 |
| Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia Fusidic Acid, Vehicle cream - Leishmaniasis, Cutaneous | Phase 3 | Not yet recruiting | Institute of Tropical Medicine, Belgium | 180 | 2025-04-01 | 2024-11-19 |
Showing 20 of 261. Sign in to see all of them.
Leishmaniasis, Cutaneous (102) · Leishmaniasis (71) · Scabies (50) · Onchocerciasis (35) · Lice Infestations (28) · Leishmaniasis, Mucocutaneous (21) · Neglected Diseases (13) · Elephantiasis, Filarial (12) · Leishmaniasis, Visceral (11) · Parasitic Diseases (9) · Filariasis (8) · Onchocerciasis, Ocular (8) · Epilepsy (5) · Hyperthermia (5) · Skin Diseases (5)
Infections (258) · Skin and Connective Tissue Diseases (258) · Skin Diseases, Infectious (257) · Skin Diseases (255) · Parasitic Diseases (252) · Vector Borne Diseases (163) · Protozoan Infections (150) · Euglenozoa Infections (149) · Ectoparasitic Infestations (79) · Leishmaniasis (78) · Mite Infestations (50) · Secernentea Infections (42) · Nematode Infections (41) · Helminthiasis (40)
Ivermectin (30) · miltefosine (29) · Meglumine Antimoniate (23) · Permethrin (15) · Albendazole (11) · Antimony Sodium Gluconate (10) · Paromomycin (9) · moxidectin (8) · spinosad (5) · Azithromycin (4) · Data Collection (4) · Malathion (4) · Pentoxifylline (4) · Suspensions (4) · liposomal amphotericin B (4)
U.S. Army Medical Research and Development Command (16) · National Institute of Allergy and Infectious Diseases (NIAID) (12) · Institute of Tropical Medicine, Belgium (11) · Hospital Universitário Professor Edgard Santos (9) · Medicines Development for Global Health (8) · Access to Advanced Health Institute (AAHI) (7) · Drugs for Neglected Diseases (7) · Sun Pharmaceutical Industries, Inc. (7) · Washington University School of Medicine (6) · Centro Internacional de Entrenamiento e Investigaciones Médicas (5) · Fundacion Nacional de Dermatologia (5) · Knight Therapeutics (USA) Inc (5) · London School of Hygiene and Tropical Medicine (5) · Centre Hospitalier de Cayenne (4) · ParaPRO LLC (4)
United States (46) · Brazil (23) · Colombia (17) · Bolivia (14) · Ethiopia (13) · Pakistan (10) · France (9) · Ghana (9) · United Kingdom (9) · Democratic Republic of the Congo (7) · Peru (7) · Israel (6) · Tunisia (6) · Fiji (5) · Germany (5)
Gary Weil, MD (4) · Jaime Soto, MD (4) · Afif Ben Salah, M.D., Ph.D. (3) · Paulo RL Machado, MD, PhD (3) · Alejandro Llanos-Cuentas, MD, PhD (2) · Armando O. Schubach, MD, PhD (2) · Charles Lacey, BMBS, MD (2) · Christopher King, MD PhD (2) · Edgar M Carvalho, MD, PhD (2) · Franco M Piazza, MD, MPH (2) · Franco Piazza, MD, MPH (2)
PMID 28379954, PMID 17845167, PMID 23877689, PMID 34053461, PMID 11353640, PMID 19415122, PMID 19636365, PMID 19936297, PMID 20016847, PMID 20220184, PMID 20231896, PMID 20438389, PMID 20851080, PMID 21200420, PMID 21337950, PMID 21460008, PMID 22238470, PMID 22594858, PMID 23388004, PMID 23390069, PMID 23740007, PMID 24968000, PMID 26092045, PMID 27803094, PMID 27927991, PMID 27956421, PMID 28558061, PMID 28855148, PMID 29361335, PMID 29898753, PMID 29985978, PMID 29988004, PMID 30044792, PMID 30252856, PMID 30260376, PMID 30379814, PMID 30815688, PMID 31314757, PMID 31923177, PMID 32055862, PMID 32561912, PMID 32589632, PMID 32894278, PMID 32976514, PMID 33253864, PMID 33728462, PMID 33781913, PMID 33909619, PMID 34048461, PMID 34693027
U19AI065866 (3), 2019 (2), 2023 (2), 2015 (1), 2016 (1), 2018 (1)